Терапия и профилактика посттравматического стрессового расстройства при чрезвычайных ситуациях (алгоритм биологической терапии) : Алгоритм биологической терапии
С. Н. Мосолов · Современная терапия психических расстройств · 2022
Post-traumatic stress disorder (PTSD) is a severe mental condition that is classified as anxiety spectrum disorder, frequently have chronic course and lead to serious consequences for the patient’s personal, family, labour and social functioning. PTSD is characterized by wide range of anxiety, neurotic, affective and psychotic symptoms that are usually challenging to manage. The combination of pharmacotherapy and psychotherapy is considered the most effective strategy for PTSD treatment. Only three selective serotonin reuptake inhibitors – sertraline, paroxetine, fluoxetine, and оne selective serotonin and norepinephrine reuptake inhibitor – venlafaxine have been approved by the international clinical guidelines as first-line treatment for PTSD. Some atypical antipsychotics, anticonvulsants, alpha-adrenergic blockers, and benzodiazepines are used to augment the response to antidepressants and psychotherapy or to control various PTSD symptoms. Certain experimental treatment options are also noteworthy and need further investigation, including hormonal neuromodulators, cannabinoid receptor antagonists, antagonists of metabotropic glutamate receptors, glucocorticoid receptor antagonists, some psychostimulants and anti- inflammatory drugs, as well as new neurostimulation techniques, like transcranial magnetic stimulation. However, only half of PTSD patients achieve remission that in real clinical practice led to wide spread of symptomatic and off-label treatment, as well as to polypharmacy in attempts to control various comorbid psychopathological symptoms. In this narrative review we analyze the available literature and evidence-based research data of PTSD treatment and prevention, and propose the prescribing algorithm for PTSD biological therapy
Cited by 0 works. Open-access PDF